BEN-MAIMON CAROLE
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to BEN-MAIMON CAROLE. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| LRMR | President and CEO | Award / Grant | 91,000 | — | — | Jan 22, 2025 |
| LRMR | President and CEO | Award / Grant | 66,125 | — | — | Jan 17, 2024 |
| LRMR | President and CEO | Purchase | 5,000 | $3.71 | $18,550 | May 17, 2023 |
| LRMR | President and CEO | Award / Grant | 205,000 | — | — | Jan 31, 2023 |
| LRMR | President and CEO | Purchase | 31,746 | $3.15 | $100,000 | Sep 16, 2022 |
| LRMR | President and CEO | Other | 25,083 | — | — | Jun 26, 2020 |
| 0000352998 | Purchase | 10,000 | $0.59 | $5,900 | May 30, 2019 | |
| 0000352998 | Purchase | 1,400 | $3.48 | $4,872 | Nov 13, 2017 | |
| 0001003642 | President, Global Pharm. | Award / Grant | 23,000 | — | — | May 14, 2014 |
| 0001003642 | President, Global Pharm. | Option Exercise | 6,734 | $18.93 | $127,475 | Oct 25, 2013 |
| 0001003642 | President, Global Pharm. | Option Exercise | 5,282 | $18.93 | $99,988 | Oct 10, 2013 |
| 0001003642 | President, Global Pharm. | Tax Withholding | 399 | $18.60 | $7,421 | May 23, 2013 |
| 0001003642 | President, Global Pharm. | Award / Grant | 24,800 | — | — | May 15, 2013 |
| 0001003642 | President, Global Pharm. | Tax Withholding | 1,836 | $24.34 | $44,688 | Oct 28, 2012 |
| 0001003642 | President, Global Pharm. Div. | Award / Grant | 4,333 | — | — | May 23, 2012 |
| 0001003642 | President, Global Pharm. Div. | Award / Grant | 24,000 | — | — | Oct 28, 2011 |